Logo

Visby's POC COVID-19 Test Receives the US FDA's EUA for Use in CLIA Waived Settings

Share this

Visby's POC COVID-19 Test Receives the US FDA's EUA for Use in CLIA Waived Settings

Shots:

  • The US FDA has granted EUA for rapid PCR COVID-19 test use at the POC and authorized for use in CLIA waived settings
  • Visby device is easy to use with the potential capability of running pooled tests in the future. The test is contained on a small- palm-sized device that plugs into a power outlet and is designed to deliver results within 30mins.
  • Visby Medical's test is able to provide fast- accurate and actionable results at the point of need. The company will continue to work to expand authorized use cases to help provide a sense of security to critical areas and allow people to return to work safely

 ­ Ref: PRNewswire | Image: PRNewswire

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions